Natural killer cell-based immunotherapy in cancer: current insights and future prospects

被引：152

作者：

Sutlu, T. ^{[1
]}

Alici, E. ^{[1
]}

机构：

[1] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Haematol,Dept Med, Stockholm, Sweden

来源：

JOURNAL OF INTERNAL MEDICINE | 2009年 / 266卷 / 02期

关键词：

cancer immunotherapy; clinical trials; cytokines; ex vivo expansion; gene therapy; natural killer cells; ACUTE MYELOID-LEUKEMIA; LOW-DOSE INTERLEUKIN-2; CHRONIC MYELOGENOUS LEUKEMIA; EFFICIENT GENE-TRANSFER; REGULATORY T-CELLS; EX-VIVO EXPANSION; TUMOR-INFILTRATING LYMPHOCYTES; COLONY-STIMULATING FACTOR; NKG2D LIGAND EXPRESSION; BLOOD MONONUCLEAR-CELLS;

D O I：

10.1111/j.1365-2796.2009.02121.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

As our understanding of the molecular mechanisms governing natural killer (NK) cell activity increases, their potential in cancer immunotherapy is growing increasingly prominent. This review analyses the currently available preclinical and clinical data regarding NK cell-based immunotherapeutic approaches in cancer starting from a historical background and an overview of molecular mechanisms taking part in NK cell responses. The status of NK cells in cancer patients, currently investigated clinical applications such as in vivo modulation of NK cell activity, ex vivo purification/expansion and adoptive transfer as well as future possibilities such as genetic modifications are discussed in detail.

引用

页码：154 / 181

页数：28

共 255 条

[1] Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model [J].

Alici, Evren ;

Konstantinidis, Kyriakos V. ;

Sutlu, Tolga ;

Aints, Alar ;

Gahrton, Gosta ;

Ljunggren, Hans-Gustaf ;

Dilber, M. Sirac .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (12) :1839-1846

[2] Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components [J].

Alici, Evren ;

Sutlu, Tolga ;

Boejrkstrand, Bo ;

Gilljam, Mari ;

Stellan, Birgitta ;

Nahi, Hareth ;

Quezada, Hernan Concha ;

Gahrton, Goesta ;

Ljunggren, Hans-Gustaf ;

Dilber, M. Sirac .

BLOOD, 2008, 111 (06) :3155-3162

[3]

Alici Evren, 2009, V506, P127, DOI 10.1007/978-1-59745-409-4_10

[4] Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial [J].

Arai, S. ;

Meagher, R. ;

Swearingen, M. ;

Myint, H. ;

Rich, E. ;

Martinson, J. ;

Klingemann, H. .

CYTOTHERAPY, 2008, 10 (06) :625-632

[5] FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS [J].

ARASE, H ;

ARASE, N ;

SAITO, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1235-1238

[6]

ARDIZZONI A, 1994, CANCER, V73, P1353, DOI 10.1002/1097-0142(19940301)73:5<1353::AID-CNCR2820730508>3.0.CO

[7]

2-H

[8] EXPANSION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS CORRELATES WITH CLINICAL OUTCOME IN CANCER-PATIENTS RECEIVING RECOMBINANT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA(2) [J].

ATZPODIEN, J ;

KIRCHNER, H ;

KORFER, A ;

HADAM, M ;

SCHOMBURG, A ;

MENZEL, T ;

DECKERT, M ;

FRANZKE, A ;

VOLKENANDT, M ;

DALLMANN, I ;

GROSSE, J ;

POLIWODA, H .

TUMOR BIOLOGY, 1993, 14 (06) :354-359

[9] INTERLEUKIN-12 (IL-12) INDUCES TYROSINE PHOSPHORYLATION OF JAK2 AND TYK2 - DIFFERENTIAL USE OF JANUS FAMILY TYROSINE KINASES BY IL-2 AND IL-12 [J].

BACON, CM ;

MCVICAR, DW ;

ORTALDO, JR ;

REES, RC ;

O'SHEA, JJ ;

JOHNSTON, JA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :399-404

[10] INTERLEUKIN-12 INDUCES TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT4 IN HUMAN-LYMPHOCYTES [J].

BACON, CM ;

PETRICOIN, EF ;

ORTALDO, JR ;

REES, RC ;

LARNER, AC ;

JOHNSTON, JA ;

O'SHEA, JJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7307-7311

← 1 2 3 4 5 6 7 8 9 10 →